Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP478109.RASDGuZF__wlTHdB7HNlAWgPInrV4UcDBbKQTZ7Nt5E2k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP478109.RASDGuZF__wlTHdB7HNlAWgPInrV4UcDBbKQTZ7Nt5E2k130_assertion type Assertion NP478109.RASDGuZF__wlTHdB7HNlAWgPInrV4UcDBbKQTZ7Nt5E2k130_head.
- NP478109.RASDGuZF__wlTHdB7HNlAWgPInrV4UcDBbKQTZ7Nt5E2k130_assertion description "[GSTM1 deletion is significantly associated with the increased risk of symptomatic BPH, but none of the GST polymorphisms appears associated with response to standard BPH therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478109.RASDGuZF__wlTHdB7HNlAWgPInrV4UcDBbKQTZ7Nt5E2k130_provenance.
- NP478109.RASDGuZF__wlTHdB7HNlAWgPInrV4UcDBbKQTZ7Nt5E2k130_assertion evidence source_evidence_literature NP478109.RASDGuZF__wlTHdB7HNlAWgPInrV4UcDBbKQTZ7Nt5E2k130_provenance.
- NP478109.RASDGuZF__wlTHdB7HNlAWgPInrV4UcDBbKQTZ7Nt5E2k130_assertion SIO_000772 21133626 NP478109.RASDGuZF__wlTHdB7HNlAWgPInrV4UcDBbKQTZ7Nt5E2k130_provenance.
- NP478109.RASDGuZF__wlTHdB7HNlAWgPInrV4UcDBbKQTZ7Nt5E2k130_assertion wasDerivedFrom befree-20140225 NP478109.RASDGuZF__wlTHdB7HNlAWgPInrV4UcDBbKQTZ7Nt5E2k130_provenance.
- NP478109.RASDGuZF__wlTHdB7HNlAWgPInrV4UcDBbKQTZ7Nt5E2k130_assertion wasGeneratedBy ECO_0000203 NP478109.RASDGuZF__wlTHdB7HNlAWgPInrV4UcDBbKQTZ7Nt5E2k130_provenance.